Biomolecules and Therapeutics
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.9 | Q1 | 79.5% | 0.969 | Q2 | 83.1% |
| 2024 | 3.2 | Q2 | 64.6% | 1.054 | Q1 | 85.5% |
| 2023 | 3.0 | Q2 | 62.5% | 0.843 | Q2 | 81.3% |
| 2022 | 3.7 | Q2 | 67.7% | 0.882 | Q1 | 83.3% |
| 2021 | 4.2 | Q2 | 71.1% | 0.965 | Q1 | 85.8% |
| 2020 | — | — | 0.977 | Q1 | 84.9% | |
| 2019 | — | — | 0.920 | Q1 | 83.8% | |
| 2018 | — | — | 0.939 | Q1 | 82.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2005-4483
ISSN
1976-9148
country
KRcoverage
2008-2026